The global peptide therapeutics market is expected to reach USD 48.04 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for efficient & rapid-acting therapeutics for treatment of cancer and other lifestyle-associated disorders, which result in lesser adverse effects, are anticipated to propel market growth.
Rising
incidence of cancer calls for exploring and introducing other means of
therapies and low-cost treatment alternatives. Moreover, growing base of
geriatric population is expected to widen the consumer base by triggering
incidence rate of target diseases such as cancer & diabetes, which are
expected to drive the demand for peptide therapeutics.
Technological
advancements in peptide manufacturing process is one of the major factors
driving the market growth during the forecast period. Manufacturers and
suppliers are focusing on the adoption of novel technologies to manufacture
efficient drug molecules with low time and capital investment. Improvement in
purification & automation process and less generation of waste is an
additional factor attributing toward market growth
For Full Research Report On Peptide Therapeutics Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/peptide-therapeutics-market
Further Key
Findings From the Study Suggest:
- Cancer held the largest
market share in 2016 owing to increasing demand for alternative
therapeutics over conventional treatment options. Peptides are being used
as potential therapeutic agents in cancer treatment.
- The generic drug segment is
expected to showcase upward shift due to patent expiration of blockbuster
peptides and supportive government initiatives pertaining to the
introduction of generic class
- Outsourced manufacturing is
expected to grow at CAGR of 6.7% owing to requirements of complex
procedures and shift in preference toward outsourcing, which helps in
eliminating cost of production.
- Route of administration
including nasal and intradermal routes is expected to grow at a rapid pace
owing to ease of usage and advantages over other routes of administration
such as oral.
- Hybrid technology is
expected to spearhead the growth of this market. Benefits associated with
this technology such as time conservation and ease of usage for both
solid- and liquid-phase peptide synthesis are the key factors affirming
growth.
- North America held the
largest share in terms of revenue in 2016 owing to higher level of
awareness pertaining to genomics & proteomics products,
well-established R&D infrastructure, and rising funding initiatives
- Asia Pacific industry is
expected to showcase lucrative growth over the forecast period with CAGR
of 11.0%. Presence of established generic industry and API providers in
this region coupled with growing economic stability in some of the
countries is expected to propel market growth.
- Some of the key players in
the peptide therapeutics market include Eli Lilly and Company; Pfizer,
Inc.; Amgen, Inc.; Takeda Pharmaceutical Company Limited; Teva
Pharmaceuticals Industries Ltd.; Lonza Inc.; Sanofi; Bristol-Myers Squibb
(BMS); AstraZeneca PLC; GlaxoSmithKline plc (GSK); Novartis AG; and Novo
Nordisk A/S
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/peptide-therapeutics-market/request/rs1
Grand View Research has segmented
the peptide therapeutics market by application, type, type of manufacturers,
route of administration, synthesis technology, and region:
Peptide
Therapeutics, Application Outlook (Revenue, USD Million; 2014 - 2025)
- Cancers
- Metabolic
- Cardiovascular Disorder
- Respiratory
- GIT
- Antiinfection
- Pain
- Dermatology
- CNS
- Renal
- Others
Peptide
Therapeutics, Type Outlook (Revenue, USD Million; 2014 - 2025)
- Generic
- Innovative
Peptide
Therapeutics, Type of Manufacturers Outlook (Revenue, USD Million; 2014 - 2025)
- In-house
- Outsourced
Peptide
Therapeutics, Route of Administration Outlook (Revenue, USD Million; 2014 -
2025)
- Parenteral Route
- Oral Route
- Pulmonary
- Mucosal
- Others
Peptide
Therapeutics, Synthesis Technology Outlook (Revenue, USD Million; 2014 - 2025)
- Solid Phase Peptide
Synthesis (SPPS)
- Liquid Phase Peptide
Synthesis (LPPS)
- Hybrid Technology
Peptide
Therapeutics, Regional Outlook (Revenue, USD Million; 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- China
- Japan
- India
- Latin America
- Mexico
- Brazil
- MEA
- South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based
market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment